期刊文献+

ZT胶碘油混合物选择性门静脉栓塞的实验研究

Experimental study of selective portal vein embolization with the mixture of ZT glue and lipiodol
原文传递
导出
摘要 目的探讨ZT胶碘油混合物行兔选择性门静脉栓塞(SPVE)的可行性。方法新西兰白兔16只,随机分为2组,A组为ZT胶碘油(1:2)混合物组,B组为碘油组,数字减影血管造影下对门静脉左支进行SPVE,观察各组栓塞材料的分布特点、术后30d肝脏组织病理学和右肝重/全肝重的变化。结果A组呈永久性栓塞,B组出现再通;栓塞侧肝叶萎缩、纤维化,非栓塞侧肝叶代偿性增生肥大;右肝重/全肝重A组为(69.41±5.10)%,B组为(39.00±6.58)%,2组比较,差异有统计学意义(P〈0.05)。结论ZT胶碘油(1:2)混合物进行SPVE,呈永久性栓塞.能诱导被栓塞肝叶萎缩未栓塞肝叶代偿性增生肥大。 Objective To evaluate the feasibility of Selective Portal Vein Embolization (SPVE) in Tabbits with the mixture of ZT glue and Lipiodol. Methods Sixteen white New Zealand rabbits were randomly divided into 2 groups : Group A, ZT glue : Lipiodol ( 1 : 2) mixture and Group B Lipiodol group. SPVE of left branch was performed in each group under digit.al subtraction angiography. The distribution feature of the embolic agents and the histopathology of liver in each group were observed. The weight ratio of the right lobe to the whole liver at the 30th day after SPVE were recorded and analyzed. Results Permanent embolization were occurred in group A. Recanalization was appeared in group B. Atrophy of the embolized lobes and compensatory hypertrophy of none-embolized lobes was observed. The weight ratio of the right lobe to the whole liver was 69.41±5.10% in group A. There was statistical difference between these two groups ( P 〈 0. 05 ). Conclusion There were permanent embolization after SPVE with the mixture of ZT glue and lipiodol. SPVE induced atrophy of the embolized lobes of liver and compensatory hypertrophy of none-embolized lobes.
出处 《中国医师杂志》 CAS 2008年第9期1196-1198,共3页 Journal of Chinese Physician
基金 广东省深圳市卫生局科技资助项目(200104093)
关键词 组织粘合剂/投药和剂量 碘化油/投药和剂量 栓塞 治疗性 门静脉 Tissue adhesives/AD Iodized oil/AD Embolization, therapeutic Portal vein
  • 相关文献

参考文献4

二级参考文献49

  • 1Lu MD,Chen JW,Xie XY,Liang LJ,Huang JF.Portal vein embolization by fine needle ethanol injection :experimental and clinicalstudies[J].World Journal of Gastroenterology,1999,5(6):506-510. 被引量:15
  • 2刘海,彭永红,杨作衡,王国雄,汤鹏.术前门静脉栓塞提高肝癌手术切除率[J].中华普通外科杂志,2004,19(9):582-583. 被引量:9
  • 3HaiLiu YongFu.Portal vein embolization before major hepatectomy[J].World Journal of Gastroenterology,2005,11(14):2051-2054. 被引量:13
  • 4项灿宏,姚力,李启东,王文跃,刘霞,王泰龄,王成钢.经皮经肝门静脉栓塞术在肝门部胆管癌手术中的应用[J].中国微创外科杂志,2007,7(1):50-53. 被引量:14
  • 5Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, Schulte am Esch J, Rogiers X. Portal vein embolization vs portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002; 6: 905-913.
  • 6Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF, Vauthey JN. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237: 686-691.
  • 7Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, Denys A, Sauvanet A. Portal vein embolization before right hepatectomy: Prospective clinical trial. Ann Surg 2003; 237: 208-217.
  • 8Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Wolf P, Greget M. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 2003; 185: 221-229.
  • 9Schweizer W, Duda P, Tanner S, Balsiger D, Hoflin F, Blumgart LH, Zimmermann A. Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein, but not bile duct obstruction, is the main driving force for the development of AHC in the rat. J Hepatol 1995; 23: 71-78.
  • 10Takayasu K, Muramatsu Y, Shima Y, Moriyama N, Yamada T, Makuuchi M. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986; 160: 389-393.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部